Results 161 to 170 of about 152,699 (284)

Cardiotoxicity associated with antineoplastic agents: a pharmacovigilance study based on FDA adverse event reporting system. [PDF]

Ther Adv Drug Saf
Qiu X, Li Q, Rong Y, Wang L, Ke J, Wang M, Zeng H, Gu J.   +7 more
europepmc   +1 more source

A LC-MS/MS based methodology for the environmental monitoring of healthcare settings contaminated with antineoplastic agents. [PDF]

J Public Health Res, 2023
Charlier B, Coglianese A, De Rosa F, Cozzolino A, Boccia G, Borrelli A, Capunzo M, Genovese G, De Caro F, Filippelli A, Dal Piaz F, Izzo V.   +11 more
europepmc   +1 more source

GPCRs in CAR‐T Cell Immunotherapy: Expanding the Target Landscape and Enhancing Therapeutic Efficacy

Advanced Science, EarlyView.
Chimeric antigen receptor T cell therapy faces dual challenges of target scarcity and an immunosuppressive microenvironment in solid tumors. This review highlights how G protein‐coupled receptors can serve as both novel targets to expand the therapeutic scope and functional modules to enhance CAR‐T cell efficacy.
Zhuoqun Liu, Yuchen Xiao, Yamin Zhao, Lihe Dai, David J.H. Shih, Shikang Liang, Honglei Tian, Liu Liu, Feng Tian, Bing Liu, Lei Chang, Chao Zhang   +11 more
wiley   +1 more source

Combination Immunotherapy as a Promising Strategy to Overcome Immunotherapy Resistance: From Emergence to Next‐Generation Approaches

Advanced Science, EarlyView.
This review examines emerging combination immunotherapy strategies tailored to distinct tumor microenvironments and highlights next‐generation biomarkers that guide response prediction and treatment personalization. It integrates lessons from unsuccessful trials, addresses toxicity challenges, and outlines approaches for early biomarker discovery and ...
Asmita Pandey, Sudhir Kumar Rai, Li Ma, Lauren Higa, Vedbar Khadka, Hua Yang, Youping Deng   +6 more
wiley   +1 more source

Antineoplastic agents-associated hepatitis B virus reactivation: Research progress and molecular mechanisms. [PDF]

Virus Res
Xie H, Lv M, Jia Q, Wang Y, Na W, Liu Y, Chang K.   +6 more
europepmc   +1 more source

Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System. [PDF]

J Pharm Pharm Sci, 2023
Yu Z, Zhu H, Chen H, Zhu L, Liao X.
europepmc   +1 more source

Combating VEGFA‐siRNA‐Induced Metabolic Reprogramming via Glucose Utilization Deprivation

Advanced Science, EarlyView.
An ionizable lipid nanoparticle co‐delivers VEGFA siRNA and glucose oxidase to tumors to counteract VEGFA knockdown‐induced, glutamine‐driven metabolic compensation. Enzymatic glucose consumption reverses the adaptive pathways and restores metabolism toward baseline, thereby sensitizing tumors to therapy.
Lulu Zheng, Shuai Guo, Yingjixing Luo, Pengfei Wu, Haiyin Yang, Yingqiu Xie, Yuchuan Fan, Qing Liu, Bo Hu, Jia Huang, Yuanyu Huang   +10 more
wiley   +1 more source

List of antineoplastic and other hazardous drugs in healthcare settings 2012 [PDF]

The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004 (http://www.cdc.gov/niosh/docs/2004-165/).

core  

Assessing the Impact of Antidepressants on Cancer Treatment: A Retrospective Analysis of 14 Antineoplastic Agents. [PDF]

Fed Pract
Luong TT, Reinhardt BJ, Shou KJ, Kigelman OF, Greenfield KM, Torres Gutierrez EF, Zamani MK.   +6 more
europepmc   +1 more source

Improving nurses' performance in the safe handling of antineoplastic agents: a quasi-experimental study. [PDF]

BMC Nurs, 2021
Nouri A, Seyed Javadi M, Iranijam E, Aghamohammadi M.   +3 more
europepmc   +1 more source